Cipla Q4FY25 Results | Net Profit Jumps 30% YoY, Total Dividend at ₹16/Share

Cipla Ltd. reported a strong set of numbers for the fourth quarter of FY25, posting a consolidated net profit of ₹1,221.84 crore, marking a 30.1% year-on-year (YoY) increase from ₹939.04 crore a year earlier. Revenue from operations rose 8.5% YoY to ₹6,597.72 crore, driven largely by steady performance across the pharmaceuticals segment, which contributed ₹6,503.63 crore to the top line.

The company’s new ventures business posted a robust 35.4% YoY growth, with revenue rising to ₹288.48 crore. However, revenue from the US market - Cipla’s largest contributor - saw a marginal dip to $221 million, down from $226 million in the corresponding period last year, though it marginally exceeded market expectations of $220 million.

To mark its 90th anniversary, Cipla’s board has proposed a special dividend of ₹3 per share in addition to a final dividend of ₹13 per share for FY25, bringing the total payout to ₹16 per equity share (face value ₹2). The record date for the dividend has been set for June 27, 2025, subject to shareholder approval at the upcoming AGM.

Cipla shares reacted mildly to the results, trading 0.4% lower at ₹1,505.50 on the BSE in afternoon trade. The stock is down 2% year-to-date.

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.

To read the RA disclaimer, please click here.